Abstract
Objective
To evaluate whether [F-18] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) can distinguish benign from malignant solitary pulmonary nodules (SPNs) with non-solid components.
Methods
[F-18] FDG-PET/CT scans were performed on 53 consecutive patients (30 men, 23 women; mean age 65 years) who had SPNs with non-solid components identified by CT screening for lung cancer. All patients underwent surgical resection, and all lesions were pathologically proved. Visual score, maximal, and mean standardized uptake value (SUV), and maximal and mean lesion-to-normal tissue count density ratio (LNR) were calculated in all lesions. In addition, clinical characteristics, laboratory test results, and CT findings were assessed.
Results
Benign SPNs with non-solid components had a higher uptake on [F-18] FDG-PET/CT. Visual score, maximal and mean SUV, and maximal and mean LNR were significantly higher in the benign when compared with the malignant SPNs (P < 0.001). When the cutoff of 1.5 was assigned for maximal SUV, the diagnostic performance of [F-18] FDG-PET/CT in predicting benign SPN revealed 100.0% sensitivity, 96.4% specificity, and 100.0% accuracy.
Conclusions
[F-18] FDG-PET/CT is useful for the differential diagnosis of SPNs with non-solid components.
Similar content being viewed by others
References
Ost D, Fein AM, Feinsilver SH. The solitary pulmonary nodule. N Engl J Med 2003;348:2535–2542.
Gupta NC, Frank AR, Dewan NA, Redepennng LS, Rothberg ML, Mailiard JA, et al. Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-d-glucose. Radiology 1992;184:441–444.
Dewan NA, Gupta NC, Redenning LS, Phalen JJ, Frick MP. Diagnostic efficacy of FDG-PET imaging in solitary pulmonary nodules: potential role in evaluation and management. Chest 1993;104:997–1002.
Patz EF Jr, Lowe VJ, Hoffman JM, Paine SS, Burrowes P, Coleman RE, et al. Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology 1993;188:487–490.
Lowe VJ, Hoffman JM, Delong DM, Patz EF Jr, Coleman RE. Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities. J Nucl Med 1994;35:1771–1776.
Gupta NC, Maloof J, Gunel ME. Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET. J Nucl Med 1996;37:943–948.
Lowe VJ, Duhaylongsod FG, Patz EF, Delong DM, Hoffman JM, Wolfe WG, et al. Pulmonary abnormalities and PET data analysis: a retrospective study. Radiology 1997;202:435–439.
Bastarrika G, Garcia-Velloso MJ, Lozano MD, Montes U, Torre W, Spiteri N, et al. Early lung cancer detection using spiral computed tomography and positron emission tomography. Am J Respir Crit Care Med 2005;171:1378–1383.
Gould MK, Maclean CC, Kuschner WG, Rydzak CE, Owens DK. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA 2001;285:914–924.
Gould MK, Kuschner WG, Rydzak CE, Maclean CC, Demas AN, Shigemitsu H, et al. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis. Ann Intern Med 2003;139:879–892.
Jang HJ, Lee KS, Kwon OJ, Rhee CH, Shim YM, Han J. Bronchioloalveolar carcinoma: focal area of ground-glass attenuation at thin-section CT as an early sign. Radiology 1996;199:485–488.
Higashi K, Ueda Y, Seki H, Yuasa K, Oguchi M, Noguchi T, et al. Fluorine-18-FDG-PET imaging in negative in bronchioloalveolar lung carcinoma. J Nucl Med 1998;39:1016–1020.
Kim BT, Kim Y, Lee KS, Yoon SE, Cheon EM, Kwon OJ, et al. Localized form of bronchioloalveolar carcinoma: FDG-PET findings. AJR 1998;170:935–939.
Yap CS, Schiepers C, Fishbein MC, Phelps ME, Czemin J. FDG-PET imaging in lung cancer: how sensitive is it for bronchioloalveolar carcinoma? Eur J Nucl Med Mol Imaging 2002;29:1166–1173.
Herder GJ, Van Tinteren H, Comans EF, Hoekstra OS, Teule GJ, Postmus PE, et al. Prospective use of serial questionnaires to evaluate the therapeutic efficacy of 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) in suspected lung cancer. Thorax 2003;58:47–51.
Herder GJ, Golding RP, Hoekstra OS, Comans EF, Teule GJ, Postmus PE, et al. The performance of (18)F-fluorodeoxyglucose positron emission tomography in small pulmonary nodules. Eur J Nucl Med Mol Imaging 2004;31:1231–1236.
Lababede O, Meziane MA, Rice TW. TNM staging of lung cancer: a quick reference chart. Chest 1999;115:233–235.
Henschke CI, McCauley DI, Yankelevitz DF, Naidich DP, McGuinness G, Miettinen OS, et al. Early lung cancer action project: overall design and findings from baseline screening. Lancet 1999;354:99–105.
Henschke CI, Yankelevitz DF, Mircheva R, McGuinness G, McCauley D, Miettinen OS. CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules. Am J Roentgenol 2002;178:1053–1057.
Swensen SJ, Silverstein MD, Ilstrup DM, Schleck CD, Edell ES. The probability of malignancy in solitary pulmonary nodules: application to small radiologically intermediate nodules. Arch Intern Med 1997;157:849–855.
Suzuki K, Yokose T, Yoshida J, Nishimura M, Takahashi K, Nagai K, et al. Prognostic significance of the size of central fibrosis in peripheral adenocarcinoma of the lung. Ann Thorac Surg 2000;69:893–897.
Kodama K, Higashiyama M, Yokouchi H, Takami K, Kuriyama K, Mano M, et al. Prognostic value of ground-glass opacity found in small lung adenocarcinoma on high-resolution CT scanning. Lung cancer 2002;33:17–25.
Matsunaga H, Yokoi K, Anraku M. Proportion of ground-glass opacity on high-resolution computed tomography in clinical T1N0M0 adenocarcinoma of the lung: a predictor of lymph node metastasis. J Thorac Cardiovasc Surg 2002;124:278–284.
Kim EA, Johkoh T, Lee KS, Han J, Fujimoto K, Sadohara J, et al. Quantification of ground-glass opacity on high-resolution CT of small peripheral adenocarcinoma of the lung: pathologic and prognostic implications. Am J Roentgenol 2001;177:1417–1422.
Cheran SK, Nielsen ND, Patz EF Jr. False-negative findings for lung tumors on FDG positron emission tomography: staging and prognostic implications. Am J Roentgenol 2004;182:1129–1132.
Herder GJ, van Tinteren H, Golding RP, Kostense PJ, Comans EF, Hoekstra OS. Clinical prediction model of characterize pulmonary nodules: validation and added value of 18F-fluorodeoxyglucose positron emission tomography. Chest 2005;28:2490–2496.
Haslett C, Clark R, Jones H, Krausz T, Rhodes C. Neutrophil metabolic activity in localized pulmonary inflammation measured non-invasively by positron emission tomography (PET). Physiologist 1989;32:210–213.
Jones HA, Clark RJ, Rhodes CG, Schofield JB, Krausz T, Haslett C. Positron emission tomography of 18FDG uptake in localized pulmonary inflammation. Acta Radiol Suppl 1991;376:259–264.
Kapucu LO, Meltzer CC, Townsend DW, Keenan RJ, Luketich JD. Fluorine-18-fluorodeoxyglucose uptake in pneumonia. J Nucl Med 1998;39:1267–1269.
Stumpe KD, Dazzi H, Schaffner A, von Schulthess GK. Infection imaging using whole-body FDG-PET. Eur J Nucl Med 2000;27:822–832.
Alavi A, Gupta NC, Alberini JL, Hickeson M, Adam LE, Bhargava P, et al. Positron emission tomography imaging in nonmalignant thoracic disorders. Semin Nucl Med 2002;4:293–321.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tsushima, Y., Tateishi, U., Uno, H. et al. Diagnostic performance of PET/CT in differentiation of malignant and benign non-solid solitary pulmonary nodules. Ann Nucl Med 22, 571–577 (2008). https://doi.org/10.1007/s12149-008-0160-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12149-008-0160-1